Currently, three BET small molecule inhibitors, JQ1, I-BET726, and OTX015, have been examined and showed significant inhibitory effect on the growth of neuroblastoma, which provides important support for the clinical application of BET inhibitors in the treatment of neuroblastoma patients. This evidence concerns the gene DNER and neuroblastoma.